Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study

Mise à jour : Il y a 5 ans
Référence : NCT00279435

Femme et Homme

Extrait

The purpose of this study is to compare the efficacy, safety, pharmacokinetics, and immunogenicity in subjects retreated with visilizumab or placebo after a response in a prior visilizumab study.


Critère d'inclusion

  • Ulcerative colitis


Liens